Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Allergic Skin Inflammation (P03475)
Status:
Completed
Trial end date:
2003-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to test the effectiveness and safety of desloratadine (Aerius)
syrup in children with allergic skin inflammation. Patients took desloratadine syrup once a
day for 28 days. Once a week, the doctor measured the patient's symptoms. This measurement is
called SCORAD. The doctor also rated how much relief the patient got from treatment and
recorded any side effects.